Kokubo et al have recently published a study of a large cohort representative of the general Japanese population (The Suita Study), in which they analyzed the association of the E65K mutation with diastolic hypertension (Circ J 2005; 69: 138 -142). The authors claimed that, contrary to our results (Fernández-Fernández, et al. J Clin Invest 2004; 113: 1032 -1039, the polymorphism E65K in the gene KCNMB1 is not associated with protection against the severity of diastolic hypertension. They based their conclusion on the lack of significant differences in the K-carrier frequency among 4 groups of diastolic blood pressure (DBP): These results, in fact, are not different from those published by us. We reported the existence of 21.6% of Kcarriers in normotensives (DBP <80 mmHg) and 15.3% in the group with DBP ≥100 mmHg, which was not statistically different. We only started to detect a significant decrease in the percentage of K-carriers in the group with DBP ≥105 mmHg (ie, severe diastolic hypertension (9.8%)), which became more pronounced (3.2%) when a further distinction was made for very severe hypertensives (DBP ≥110 mmHg). These DBP groups, unfortunately, were not regarded in the same way in the study by Kokubo et al and therefore they failed to determine whether the association between KCNMB1 E65K polymorphism and severe diastolic hypertension is also found in the Japanese population. In our opinion, the suggested ethnic differences in the involvement of E65K polymorphism in blood pressure regulation are not supported by their results, which are based on a different analysis. In conclusion, within the range of DBP analysed by Kokubo and cols., the authors replicate our results (Fernandez-Fernández et al, 2004), but the relationship of the E65K mutation with severe diastolic hypertension could not be assessed because of incomplete subgroup analysis in their study. Therefore, we kindly ask Kokubo and collaborators to correct the misleading statements of their manuscript regarding the lack of association between the E65K mutation and diastolic hypertension in the Suita Study. 
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Author's Reply The KCNB1/E65K Polymorphism is Not Associated With Low Prevalence of Diastolic Blood Pressure in a Japanese Population
We have read the comments on our paper 1 by Professor Valverde, and re-analyzed the relationship between diastolic blood pressure (DBP) and the E65K polymorphism in subjects without hypertensive medication (n=2,702).
Multiple logistic analysis in which age and BMI were included as covariates indicated that the E65K polymorphism did not have a significant effect on DBP (p=0.857). Our categorization of DBP is based on the previous report 2 and as we described, the E65K polymorphism had no significant effects on the DBP values (mmHg). Taken together, the results showed that the K allele was not associated with a protective effect against the severity of diastolic hypertension and we conclude that the significance of the KCNMB1/E65K polymorphism was not validated in our study. 
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